Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3729722017 | Betamethasone and salicylic acid only product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3729723010 | Product containing only betamethasone and salicylic acid (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
2838991000001118 | Salicylic acid + Betamethasone (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
2839001000001118 | Salicylic acid + Betamethasone | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Salicylic acid + Betamethasone | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Salicylic acid + Betamethasone | Has active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 2 | |
Salicylic acid + Betamethasone | Is a | Product containing betamethasone and salicylic acid | true | Inferred relationship | Existential restriction modifier | ||
Salicylic acid + Betamethasone | Has active ingredient | Betamethasone | true | Inferred relationship | Existential restriction modifier | 1 | |
Salicylic acid + Betamethasone | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Salicylic acid + Betamethasone | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets